View Latest Medical and Pharma Bids and Tenders

Supply of Medicine and Medical / Surgical equipments : Quality control serum for clinical\nchemistry, assayed, freeze dried,\nnormal range 5ml/vial (Pathological\nand normal should be in same source)\nPacking : 1 vial etc .

Supply of Medicine and Medical / Surgical equipments : Snake venom Antiserum 10ml vial\nSnake Venom Antiserum IP (96)\nTo Neutralise the Venoms of the Cobra (Naja\nnaja)*,Russelle's viper (Vipera russelli)* the\nCommon Krait (Bungarus caeruleus) an Saw\nscaled viper (Echis-carinatus Reg) in a\nLyophillised sterile powder form, to dilute with\nwater for injections BP/USP/IP.\nEach vial to contain sufficient powder to\nprepare 10ml of refined Globulin solution to\nmeet the following conditions.\n1. Product should conform to potency test IP\n1ml of reconstituted serum should neutralize\nnot less than the following quantities of\nstandard venoms when tested in white mice of\nNIH Strain and weight between 18 - 20g\nCobra (Naja naja).0.6mg\nCommon Krait (Bangarus\ncaeruleus).0.45mg,\nRussell's Viper (Viperrusselli).0.6mg\nSaw-scaled Viper(Echis-carinatus\nReg).0.45mg (Product should contain at\nleast 10% of excess potency at the time of\nsupply)\n2. Abnormal toxicity: test should conform to IP\nstandard.\n3.Each consignment should have a minimum\nremaining shelf life of 75% at the time of\nreceiving the consignment at MSD.\nNote: The following documents should be\nsubmitted pre- shipment for each lot of serum\ndispatched.\n1. Summary protocols for production and\nquality testing (Including protocols for\nimmunization, initial pool, final bulk and finished\nproduct ) based on WHO model summary\nprotocols.\n2. Lot release certificate from National Control\nLaboratory of manufacturing country for that\nparticular batch.\n3. Certificate of analysis of finished product.\n4. Certificate of analysis of diluents, if\napplicable.\n5. The package information leaflet. etc .

Supply of Medicine and Medical / Surgical equipments : Anti Rabies serum (equine) Injection 1,000\nIU in 5ml Ampoule.\nRabies Antiserum BP 1000 IU/5mL OR\nAnti Rabies Serum USP 1000 IU/5mL\nEach 5mL ampoule to contain 1000 IU of\nRabies Antiserum BP or Anti Rabies Serum\nUSP\nNote 1:\n1. This injection should be stable for 24 months\nwhen stored within a temperature range of 2'C-\n8'C. Do not freeze.\n2. Each consignment should have a minimum\nremaining shelf life of 75% at the time of\nreceiving the consignment at MSD.\n3. Cold chain monitors should be included for\neach carton and cold chain should be\nmaintained according to the manufacturer's\ninstructions during storage, transport and\ndelivery of item.\n4. Each vial should be labelled accordingly.\nNote\nThe following documents should be submitted\npre- shipment for each lot of serum dispatched.\n1. Summary protocols for production and\nquality testing (Including protocols for\nimmunization, initial pool, final bulk and finished\nproduct ) based on WHO model summary\nprotocols.\n2. Lot release certificate from National Control\nLaboratory of manufacturing country for that\nparticular batch.\n3. Certificate of analysis of finished product.\n4. Certificate of analysis of diluents, if\napplicable.\n5. The package information leaflet.\nPacking : One vial etc .

Supply of Medicine and Medical / Surgical equipments : Anti D.(Rho) Immunoglobulin (Human)\nInjection 300microgam in 1.5ml\nampoule/vial\nAnti D. (Rho) Immunoglobulin injection BP\nEach colourless glass ampoule or vial to\ncontain liquid or freeze dried preparation\ncontaining 300mcg (1500 IU) of Anti D (Rho)\nImmunoglobulin (Human)obtained from plasma\nor serum of D-negative donors who have been\nimmunized against the Rhesus D-antigen for\nintramuscular injection.\nOR\nEach colourless glass ampoule or vial to\ncontain liquid or freeze dried preparation\ncontaining 300mcg (1500 IU) of Anti D (Rho)\nImmunoglobulin (Monoclonal) derived from\nHeterohybridoma for intramuscular injection.\nNote:\n1.The volume of ampoule/vial can be up to\nmaximum of 2ml.\n2. This injection should be stable for a\nminimum of 24 months when stored within the\ntemperature range of 2'C - 8'C. Do not freeze.\n3.Each consignment should have a minimum\nremaining shelf life of 75% at the time of\nreceiving the consignment at MSD.\n4. Manufacturer should also conform that the\nproduct offered is free from Hepatitis B virus\nand Hepatitis C virus.\n5. The product should be protected from light\nby suitable packaging.\n6. Each ampoule/vial should be labelled\naccordingly.\nPacking : One vial etc .

Supply of Medicine and Medical / Surgical equipments : Anti Rabies Serum (Equine) Injection 1,000 etc .

Supply of Medicine and Medical / Surgical equipments : Cardiac Troponin I qualitative strips\n1. The Troponin assay test strip should be able\nto detect cardiac Troponin I(cTnI) in serum\n/plasma/whole blood cTnI.\n2. The method of analyzing cTn should be\nbased on double antibody lateral flow\nImmunoassay technique with specific\nantibodies to cTnI to provide maximum\nspecificity.\n3. The reaction time should be less than 20\nminutes for each test.\n4. Should be very sensitive with a cutoff point\nof cTnI not more than 1 ng/mL and preferably\n0.5 ng/mL.\n5. Stirp should have a built in quality control\nfeature control line" which indicates defective\nstripm inadequate volume or inadequate flow\nof the sample.\n6. Minimum serum volume required should be\nnot more than 200 micro litre.\n7. Traceability certificate should be available\n8. Supply of positive and Negative controls are\npreferable.\n9. Additional instruments should not be\nrequired to perform the test except using a\npipette and the strip. If any additional\ninstruments required, it should be supplied by\nthe strip provider “Free of charge” for all users.\n10. Should have Cosmetic Devices Drug\nAuthority (CDDA) / National Medicinal\nRegulatory Authority (NMRA) certificate.\nPacking : 25 strips etc .

Supply of Medicine and Medical / Surgical equipments : Reagent kit for serum creatinine estimation:\ncolorimetric kinetic (alkaline-picrate) method\n,double reagent R1,R2 (200tests/kit) with\nstandards\nPacking : 1 Kit etc .

Supply of Medicine and Medical / Surgical equipments : ELISA test for detection of IgM antibodies to\nHerpes simplex virus 1 in Human serum (96\ntests/kit)\nPacking : 1 kit etc .

Supply of Medicine and Medical / Surgical equipments : Elisa Test kit for detection of HIV P24 antigen\nand antibodies to HIV; HIV 2 and HIV vi sub\ntype „O‟ antigen\n1. Test kit should detect of HIV P24 antigen\nand antibodies to HIV-1 (groups M and O)\nand HIV-2 inhuman serum or plasma.\n2. Number of tests shall be performed =480\ntests per kit\n3. Sensitivity should be 100%\n4. Specificity should be more than 99%\n5. Residual shelf life at the time of delivery\nshould be minimum of 18 months\n6. Each test kit should include adequate\npositive and negative controls\n7. Shall give a color change once serum is\nadded to the reagents.\n8. Precautions must be taken to maintain the\ncold chain while transportation until it reaches\nthe blood bank, as these\nreagents are kept at 2-6C.\n9. Reagent brochure, labels and any other\ninformation provided should be in English\nlanguage.\n10. Reagent shall contain FDA certification\nand/or WHO certification/ EU Quality\ncertification /free sales certificate and\ncertificate of use in the country in country of\norigin/ end user evaluation certificate/ or free\nsales certificate in USA, UK, France, Germany,\nCanada, New Zealand or Australia with\nstandard quality certificates etc .

Supply of Medicine and Medical / Surgical equipments : ELISA test kit for the detection of Antigen &\nAntibodies to HCV 4th Gen (Hepatitis C Virus)\n1. Test kit should detect HCV antigen and\nantibodies in human serum or plasma.\n2. Number of tests shall be performed =480\ntests per kit\n3. Sensitivity should be 100%\n4. Specificity should be more than 99%\n5. Residual shelf life at the time of delivery\nshould be minimum of 18 months\n6. Each test kit should include adequate\nnegative and positive controls\n7. Shall give a color change once serum is\nadded to the reagents.\n8. Precautions must be taken to maintain the\ncold chain while transportation until it reaches\nthe blood bank, as thesem reagents are kept\nat 2-6 C.\n9. Reagent brochure, labels and any other\ninformation provided should be in English\nlanguage.\n10. Reagent shall contain FDA certification\nand/or WHO certification/ EU Quality\ncertification /free sales certificate and\ncertificate of use in the country in country of\norigin/end user evaluation certificate/ or free\nsales certificate in USA, UK, France, Germany,\nCanada, New Zealand or Australia with\nstandard quality certificates etc .